Login / Signup

No impact of CD34 + cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma.

Tristan E KnightKwang Woo AhnKyle M HebertRasha AtshanDonna A WallKanhatai ChiengthongTroy C LundTim PrestidgeHemalatha G RangarajanChristopher C DvorakJeffery J AulettaMichael KentHasan HashemJulie-An TalanoSeth J RotzEllen FraintKasiani C MyersWing LeungAkshay SharmaNeel S BhattTimothy A DriscollLolie C YuKirk R SchultzMuna QayedLarisa BroglieMary EapenGregory A Yanik
Published in: Bone marrow transplantation (2023)
Keyphrases
  • hematopoietic stem cell
  • cell therapy
  • single cell
  • young adults
  • bone marrow
  • platelet rich plasma